Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy

Published:2019-05 Issue:2 Volume:153 Page:376-380
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Lim Stephanie L.,Havrilesky Laura J.,Habib Ashraf S.,Secord Angeles Alvarez

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference31 articles.

1. Survival Rates for Ovarian Cancer, by Stage;Society AC,2018

2. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study;Glehen;J. Clin. Oncol.,2003

3. Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP- NTC01226394);Goere;J. Clin. Oncol.,2018

4. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7;Quenet;J. Clin. Oncol.,2018

5. Evaluation of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin in the Era of Value-Based Medicine;Vanounou;Ann. Surg. Oncol.,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological outcomes and hospitalization cost of hyperthermic intraperitoneal chemotherapy (HIPEC) open and closed abdomen techniques: Results from two French expert centers;European Journal of Surgical Oncology;2024-02

2. Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience;International Journal of Gynecologic Cancer;2023-11-27

3. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer;Annals of Surgical Oncology;2023-06-26

4. Cost-effectiveness of hyperthermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III-IV ovarian cancer from a randomized controlled phase III trial in Korea (KOV-HIPEC-01);Gynecologic Oncology;2023-03

5. Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status;Gynecologic Oncology Reports;2022-06